KR20010021952A - 티아졸리딘디온, 인슐린 분비촉진제 및 알파 글루코시다제억제제를 사용한 당뇨병의 치료 - Google Patents

티아졸리딘디온, 인슐린 분비촉진제 및 알파 글루코시다제억제제를 사용한 당뇨병의 치료 Download PDF

Info

Publication number
KR20010021952A
KR20010021952A KR1020007000517A KR20007000517A KR20010021952A KR 20010021952 A KR20010021952 A KR 20010021952A KR 1020007000517 A KR1020007000517 A KR 1020007000517A KR 20007000517 A KR20007000517 A KR 20007000517A KR 20010021952 A KR20010021952 A KR 20010021952A
Authority
KR
South Korea
Prior art keywords
compound
insulin
administering
diabetes
pharmaceutically acceptable
Prior art date
Application number
KR1020007000517A
Other languages
English (en)
Korean (ko)
Inventor
로빈 에드윈 버킹엄
스티븐 알리스테어 스미스
Original Assignee
피터 기딩스
스미스클라인비이참피이엘시이
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 피터 기딩스, 스미스클라인비이참피이엘시이 filed Critical 피터 기딩스
Publication of KR20010021952A publication Critical patent/KR20010021952A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
KR1020007000517A 1997-07-18 1998-07-16 티아졸리딘디온, 인슐린 분비촉진제 및 알파 글루코시다제억제제를 사용한 당뇨병의 치료 KR20010021952A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9715298A GB9715298D0 (en) 1997-07-18 1997-07-18 Novel method of treatment
GB9715298.7 1997-07-18
PCT/GB1998/002112 WO1999003478A1 (en) 1997-07-18 1998-07-16 Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor

Publications (1)

Publication Number Publication Date
KR20010021952A true KR20010021952A (ko) 2001-03-15

Family

ID=10816170

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020007000517A KR20010021952A (ko) 1997-07-18 1998-07-16 티아졸리딘디온, 인슐린 분비촉진제 및 알파 글루코시다제억제제를 사용한 당뇨병의 치료

Country Status (27)

Country Link
EP (1) EP1001784A1 (no)
JP (1) JP2001510160A (no)
KR (1) KR20010021952A (no)
CN (1) CN1263467A (no)
AP (1) AP2000001735A0 (no)
AR (2) AR016350A1 (no)
AU (1) AU8449098A (no)
BG (1) BG104062A (no)
BR (1) BR9810292A (no)
CA (1) CA2297133A1 (no)
CO (1) CO4940489A1 (no)
DZ (1) DZ2563A1 (no)
EA (1) EA200000140A1 (no)
GB (1) GB9715298D0 (no)
HU (1) HUP0003626A3 (no)
ID (1) ID23804A (no)
IL (1) IL133907A0 (no)
MA (1) MA24608A1 (no)
NO (1) NO20000230D0 (no)
OA (1) OA11312A (no)
PE (1) PE99499A1 (no)
PL (1) PL338140A1 (no)
SK (1) SK612000A3 (no)
TR (1) TR200000133T2 (no)
UY (1) UY25101A1 (no)
WO (1) WO1999003478A1 (no)
ZA (1) ZA986364B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
WO2000078333A2 (en) 1999-06-21 2000-12-28 Eli Lilly And Company Synergetic use of thiazolidinediones with glucagon-like peptide-1 and agonists thereof to treat non-insulin dependant diabetes
ES2436610T3 (es) * 2000-01-21 2014-01-03 Novartis Ag Combinaciones que contienen inhibidores de la dipeptidilpeptidasa-IV y agentes antidiabéticos
JP4917712B2 (ja) * 2000-02-24 2012-04-18 武田薬品工業株式会社 併用医薬
AU2001234114A1 (en) * 2000-02-24 2001-09-03 Takeda Chemical Industries Ltd. Drugs containing combined active ingredients
US7964216B2 (en) 2001-01-12 2011-06-21 Sun Pharma Advanced Research Company Limited Spaced drug delivery system
FR2832930A1 (fr) * 2001-12-03 2003-06-06 Lipha Composition pharmaceutique comprenant un inhibiteur d'alpha-glucosidase et un derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete
US7700128B2 (en) 2003-10-31 2010-04-20 Takeda Pharmaceutical Company Limited Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester
CN101103993B (zh) * 2006-07-14 2011-03-30 北京华安佛医药研究中心有限公司 降糖药物组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993003724A1 (en) * 1991-08-26 1993-03-04 The Upjohn Company Pharmaceutical composition containing 3-guanidinopropionic acid and pioglitazone glibenclamide or glimepiride
US5917052A (en) * 1994-09-28 1999-06-29 Shaman Pharmaceuticals, Inc. Hypoglycemic agent from cryptolepis
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes

Also Published As

Publication number Publication date
BR9810292A (pt) 2000-09-19
IL133907A0 (en) 2001-04-30
EA200000140A1 (ru) 2000-06-26
BG104062A (en) 2000-11-30
NO20000230L (no) 2000-01-17
JP2001510160A (ja) 2001-07-31
AR016350A1 (es) 2001-07-04
PE99499A1 (es) 1999-12-18
TR200000133T2 (tr) 2000-09-21
EP1001784A1 (en) 2000-05-24
GB9715298D0 (en) 1997-09-24
ID23804A (id) 2000-05-11
HUP0003626A3 (en) 2001-12-28
OA11312A (en) 2003-10-24
DZ2563A1 (fr) 2003-02-15
MA24608A1 (fr) 1999-04-01
PL338140A1 (en) 2000-09-25
AR019724A2 (es) 2002-03-13
NO20000230D0 (no) 2000-01-17
CA2297133A1 (en) 1999-01-28
UY25101A1 (es) 2000-12-29
SK612000A3 (en) 2000-07-11
CO4940489A1 (es) 2000-07-24
AU8449098A (en) 1999-02-10
WO1999003478A1 (en) 1999-01-28
HUP0003626A2 (hu) 2001-05-28
ZA986364B (en) 2000-01-17
CN1263467A (zh) 2000-08-16
AP2000001735A0 (en) 2000-01-16

Similar Documents

Publication Publication Date Title
KR100666591B1 (ko) 티아졸리딘디온 및 메트포르민을 사용한 당뇨병의 치료
JP2005213273A (ja) チアゾリジンジオン、インスリン分泌促進薬およびジグアニドを用いる糖尿病の治療
JP2005247865A (ja) チアゾリジンジオンおよびスルホニル尿素を用いる糖尿病の治療
KR20010021952A (ko) 티아졸리딘디온, 인슐린 분비촉진제 및 알파 글루코시다제억제제를 사용한 당뇨병의 치료
US20050054687A1 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
KR20010013840A (ko) 티아졸리딘디온 및 술포닐우레아를 사용한 당뇨병의 치료
KR20010013845A (ko) 티아졸리딘디온 및 알파-글루코시다제 억제제를 사용한당뇨병의 치료
US20020016287A1 (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide
US20030109561A1 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
US20020052324A1 (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
US20010034356A1 (en) Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor
MXPA00000655A (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
MXPA00000633A (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide
AU2005227371A1 (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide
AU2928002A (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide
MXPA00000631A (en) Treatment of diabetes with thiazolidinedione and sulphonylurea

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid